Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Novo Nordisk A/S ADR (NVO)
Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 357,768,480
  • Shares Outstanding, K 2,243,766
  • Annual Sales, $ 25,057 M
  • Annual Income, $ 7,862 M
  • 60-Month Beta 0.48
  • Price/Sales 14.11
  • Price/Cash Flow 40.85
  • Price/Book 31.61
Trade NVO with:

Options Overview Details

View History
  • Implied Volatility 24.21% ( -0.57%)
  • Historical Volatility 25.20%
  • IV Percentile 19%
  • IV Rank 20.76%
  • IV High 37.01% on 10/12/22
  • IV Low 20.86% on 03/06/23
  • Put/Call Vol Ratio 1.87
  • Today's Volume 445
  • Volume Avg (30-Day) 2,497
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 76,564
  • Open Int (30-Day) 77,752

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 1.29
  • Number of Estimates 3
  • High Estimate 1.36
  • Low Estimate 1.21
  • Prior Year 0.84
  • Growth Rate Est. (year over year) +53.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
154.35 +2.03%
on 06/02/23
172.33 -8.61%
on 05/12/23
-11.04 (-6.55%)
since 05/09/23
3-Month
135.32 +16.38%
on 03/16/23
172.97 -8.95%
on 04/21/23
+15.46 (+10.88%)
since 03/09/23
52-Week
95.02 +65.74%
on 09/26/22
172.97 -8.95%
on 04/21/23
+44.68 (+39.60%)
since 06/09/22

Most Recent Stories

More News
Why Novo Nordisk Stock Bumped Higher Today

A fresh analyst note and a stock-repurchase program update helped the shares disobey gravity.

DB : 10.61 (-0.66%)
NVO : 157.63 (-1.14%)
Why You Should Go Overweight On Novo Nordisk Stock

Novo Nordisk is already the global kingpin in diabetes treatments, with about 30% of the $50+ billion global diabetes market and around half of the $20 billion insulin therapy market. Now, it is becoming...

NVO : 157.63 (-1.14%)
LLY : 446.99 (+0.30%)
3 Pharmaceutical Stocks to Watch

The pharmaceutical industry is anticipated to grow due to rising chronic diseases and an aging population. Given the industry's strong long-term prospects, quality stocks Novo Nordisk (NVO), Novartis (NVS),...

BMY : 65.27 (-0.06%)
NVO : 157.63 (-1.14%)
NVS : 100.23 (-0.42%)
Novo Nordisk's Smash-Hit Drug Could Become Even More Profitable. Here's Why.

Semaglutide could eventually be marketed for even more conditions than it is today.

NVO : 157.63 (-1.14%)
Could Pfizer Have an Ozempic Killer on the Way?

Pfizer hopes to compete in what could be a $100 billion to $200 billion market.

NVO : 157.63 (-1.14%)
PFE : 39.28 (+0.49%)
LLY : 446.99 (+0.30%)
3 Value Stocks to Add to Your Portfolio

The stock market will likely remain under pressure with rising concerns about an economic slump and high-interest rates. Therefore, investors could look to add fundamentally strong stocks Novo Nordisk...

NTCT : 30.21 (+0.27%)
NVO : 157.63 (-1.14%)
NVS : 100.23 (-0.42%)
Is SNDL Inc. (SNDL) Overbought?

Canadian cannabis company SNDL Inc. (SNDL) enjoys major investor attention and belongs to the Robinhood top 100 stocks list. However, should investors consider buying this stock now? Read more… ...

ABBV : 139.15 (+1.10%)
NVO : 157.63 (-1.14%)
NVS : 100.23 (-0.42%)
SNDL : 1.4200 (-2.07%)
Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond.

These stocks have moved in opposite directions lately, but both could deliver solid returns to patient investors.

NVO : 157.63 (-1.14%)
TNDM : 24.64 (+1.90%)
Does Pfizer Have a Weight-Loss Pill That's Better Than Ozempic?

A highly lucrative weight-loss market could be the growth opportunity Pfizer needs to make the stock a better buy.

NVO : 157.63 (-1.14%)
PFE : 39.28 (+0.49%)
This Could Be Novo Nordisk's Next Big Weight-Loss Product

The company's sales doubled last quarter, prompting it to upgrade its guidance.

NVO : 157.63 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bagsv'rd, Denmark-based Novo Nordisk is a global healthcare company and a leader in the worldwide diabetes market. The company is also a key player in hemophilia care, growth hormone therapy, hormone replacement therapy and obesity.Novo Nordisk operates through two segments: Diabetes and obesity care...

See More

Key Turning Points

3rd Resistance Point 162.52
2nd Resistance Point 161.19
1st Resistance Point 160.32
Last Price 157.63
1st Support Level 158.12
2nd Support Level 156.79
3rd Support Level 155.92

See More

52-Week High 172.97
Last Price 157.63
Fibonacci 61.8% 143.19
Fibonacci 50% 133.99
Fibonacci 38.2% 124.80
52-Week Low 95.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar